NCT02123537

Brief Summary

People with multiple sclerosis (MS) often suffer from foot drop, which impairs their walking ability. Foot drop is the inability to lift the foot during the swing phase of walking. The purpose of this study is to find out if electrical stimulation of the leg, using the Bioness L300 Foot Drop System, can be used to treat foot drop in people with MS. It is expected that using this system will reduce foot drop, and therefore improve walking ability, particularly in the areas of speed, strength, balance and falls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jun 2014

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 25, 2014

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

September 7, 2016

Status Verified

September 1, 2016

Enrollment Period

2.1 years

First QC Date

April 23, 2014

Last Update Submit

September 6, 2016

Conditions

Keywords

Bioness L300 Foot Drop SystemFunctional electrical stimulation

Outcome Measures

Primary Outcomes (1)

  • Speed during the 10-metre straight line walking test

    During the 10-metre straight line walking test, participants walk 10 metres, as marked on the floor with tape, at a steady, self-selected pace, with room for acceleration and deceleration before and after the test. The test measures walking speed, which assesses overall gait function and stability. Participants will complete this test both with and without using the L300 device.

    12 weeks

Secondary Outcomes (10)

  • Distance travelled during the 4-minute figure-8 walking test

    12 weeks

  • Speed during the 10-metre straight line walking test

    4 weeks

  • Speed during the 10-metre straight line walking test

    8 weeks

  • Distance travelled during the 4-minute figure-8 walking test

    4 weeks

  • Distance travelled during the 4-minute figure-8 walking test

    8 weeks

  • +5 more secondary outcomes

Study Arms (1)

Bioness L300 Foot Drop System

EXPERIMENTAL

Participants will use the Bioness L300 Foot Drop System for walking daily during the 12 weeks of the study.

Device: Bioness L300 Foot Drop System

Interventions

Participants will use the Bioness L300 Foot Drop System during waking hours for 12 weeks.

Bioness L300 Foot Drop System

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have multiple sclerosis for at least one year
  • Being 18 years of age or older
  • Have upper motor neuron-type foot drop (based on the study clinician's medical opinion)
  • Able to ambulate at least 10 metres independently or with one person assistance, with or without walking aid
  • Having the cognitive capacity to understand and follow the study protocol

You may not qualify if:

  • Severe cardio-respiratory difficulties (including using a pace-maker) or other health issues that may prohibit walking training
  • Significant lower motor neuron neuropathy (based on the study clinician's medical opinion)
  • History of frequent falls (more than once a week)
  • Having used functional electrical stimulation to treat gait within the past six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Hospital, Health Sciences Centre

Winnipeg, Manitoba, R3A 1M4, Canada

Location

Related Publications (4)

  • Laufer Y, Hausdorff JM, Ring H. Effects of a foot drop neuroprosthesis on functional abilities, social participation, and gait velocity. Am J Phys Med Rehabil. 2009 Jan;88(1):14-20. doi: 10.1097/PHM.0b013e3181911246.

    PMID: 19096288BACKGROUND
  • Ring H, Treger I, Gruendlinger L, Hausdorff JM. Neuroprosthesis for footdrop compared with an ankle-foot orthosis: effects on postural control during walking. J Stroke Cerebrovasc Dis. 2009 Jan;18(1):41-7. doi: 10.1016/j.jstrokecerebrovasdis.2008.08.006.

    PMID: 19110144BACKGROUND
  • Stein RB, Everaert DG, Thompson AK, Chong SL, Whittaker M, Robertson J, Kuether G. Long-term therapeutic and orthotic effects of a foot drop stimulator on walking performance in progressive and nonprogressive neurological disorders. Neurorehabil Neural Repair. 2010 Feb;24(2):152-67. doi: 10.1177/1545968309347681. Epub 2009 Oct 21.

    PMID: 19846759BACKGROUND
  • O'Dell MW, Dunning K, Kluding P, Wu SS, Feld J, Ginosian J, McBride K. Response and prediction of improvement in gait speed from functional electrical stimulation in persons with poststroke drop foot. PM R. 2014 Jul;6(7):587-601; quiz 601. doi: 10.1016/j.pmrj.2014.01.001. Epub 2014 Jan 9.

    PMID: 24412265BACKGROUND

MeSH Terms

Conditions

Multiple SclerosisPeroneal Neuropathies

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular Diseases

Study Officials

  • Karen D Ethans, MD

    Health Sciences Centre, Winnipeg

    PRINCIPAL INVESTIGATOR
  • Jessie R Shea, MSc

    Health Sciences Centre, Winnipeg

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Spinal Cord Rehabilitation Program

Study Record Dates

First Submitted

April 23, 2014

First Posted

April 25, 2014

Study Start

June 1, 2014

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

September 7, 2016

Record last verified: 2016-09

Locations